Furthermore, sensitivity of NPM1c AML to I-BET in vivo was confirmed following transplant of leukemia cells from three separate NPM1c AML tumors into NOD-SCID IL-2Rγ −/− recipient mice. This evidence concerns the gene IL2RG and leukemia.